Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Management of incidentalomas].

J M Duclos1

  • 1Service d'Urologie, Hôpital Saint-Joseph, Paris.

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Adrenocortical secretory tumors].

Annales d'urologie·2004
Same author

[Uneasy nephrectomies].

Annales d'urologie·2004
Same author

[Non-secreting adrenal tumours].

Annales d'urologie·2004
Same author

[Pheochromocytoma: 25 years of experience. Report of 199 cases].

Archives des maladies du coeur et des vaisseaux·2003
Same author

[The Munchausen syndrome: a diagnosis not to be forgotten in urology].

Presse medicale (Paris, France : 1983)·2002
Same author

Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

Cancer research·2001

Adrenal incidentalomas are lesions found incidentally. Diagnosis involves excluding secreting tumors and distinguishing malignant potential from benign adrenal anomalies using imaging and lab tests.

Area of Science:

  • Endocrinology
  • Radiology
  • Oncology

Context:

  • Adrenal incidentalomas are frequently discovered during imaging for unrelated conditions.
  • Accurate characterization is crucial for appropriate patient management and to avoid unnecessary interventions.

Purpose:

  • To outline diagnostic criteria for adrenal incidentalomas.
  • To differentiate between potentially malignant adrenal tumors and benign adrenal anomalies.

Summary:

  • Diagnosis involves excluding hormone-secreting tumors (e.g., phaeochromocytomas) via MRI and metanephrine assays.
  • Further evaluation includes clinical exams and assays for potassium, cortisol, and aldosterone.
  • Distinguishing operable tumors from monitored anomalies relies on initial size and growth rate via CT scans.

Related Experiment Videos

Impact:

  • Facilitates standardized diagnostic pathways for adrenal incidentalomas.
  • Improves clinical decision-making regarding surgical intervention versus surveillance.
  • Reduces patient anxiety and healthcare costs associated with unnecessary procedures.